CHLD
CHANGE OF OWNER RECEIVED FROM IB
04/09/2026
Back to search
Official data from USPTO
CYTOPE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CYTOPE
ST13
US500000079380759Class
5, 42, 45
Filing
79380759
Registration
7646529
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
04/10/2026
Trademark type
Word
Nice classes
5, 42, 45
Filing date
07/12/2023
Registration date
01/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
04/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
IE
Examiner
EULIN, INGRID C
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Prothena Biosciences Limited
Prothena Platform Technologies Limited
Representatives
Tore T. DeBella Faegre Drinker Biddle & Reath LLP
Technical classification
Nice Classes
Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of autoimmunemetastatichematologiconcologicocular and neurologic diseasesconditions and disorders; biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of diseasesconditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of diseasesconditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of amyloidosispsoriasispsoriatic arthritisrheumatoid arthritisdermatitishost and graft rejectionsAlzheimer's and Parkinson's-disease associated neuropsychiatric disordersinsulin resistancemetabolic syndrome and diabetes
Class 42
Research and development in the pharmaceutical and biotechnology fields
Class 45
Licensing of intellectual property in the field of biotechnology
Publications
History of USPTO decisions and trademark events.
33 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/26/2026
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
08/08/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/22/2025
FIMP
FINAL DISPOSITION PROCESSED
07/22/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/14/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/29/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/11/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2024
PUBO
PUBLISHED FOR OPPOSITION
11/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/17/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/17/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/17/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/17/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/17/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/19/2024
RFNT
REFUSAL PROCESSED BY IB
04/30/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/11/2024
RFRR
REFUSAL PROCESSED BY MPU
04/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/23/2024
CNRT
NON-FINAL ACTION WRITTEN
03/23/2024
DOCK
ASSIGNED TO EXAMINER
03/20/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/17/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/13/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/12/2023
Continuous trademark protection
Get notified about every new filing that threatens CYTOPE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.